Shandong Xinhua Pharmaceutical Company Statistics
Total Valuation
Shandong Xinhua Pharmaceutical Company has a market cap or net worth of HKD 8.76 billion. The enterprise value is 9.43 billion.
Market Cap | 8.76B |
Enterprise Value | 9.43B |
Important Dates
The next estimated earnings date is Thursday, October 24, 2024.
Earnings Date | Oct 24, 2024 |
Ex-Dividend Date | Sep 4, 2024 |
Share Statistics
Shandong Xinhua Pharmaceutical Company has 682.41 million shares outstanding. The number of shares has increased by 0.43% in one year.
Shares Outstanding | 682.41M |
Shares Change (YoY) | +0.43% |
Shares Change (QoQ) | +4.60% |
Owned by Insiders (%) | 0.62% |
Owned by Institutions (%) | 5.18% |
Float | 410.81M |
Valuation Ratios
The trailing PE ratio is 6.83.
PE Ratio | 6.83 |
Forward PE | n/a |
PS Ratio | 0.41 |
PB Ratio | 0.71 |
P/FCF Ratio | 164.99 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.14, with an EV/FCF ratio of 435.04.
EV / Earnings | 17.83 |
EV / Sales | 1.08 |
EV / EBITDA | 8.14 |
EV / EBIT | 16.02 |
EV / FCF | 435.04 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 28.19.
Current Ratio | 1.39 |
Quick Ratio | 0.89 |
Debt / Equity | 28.19 |
Debt / EBITDA | 1.30 |
Debt / FCF | 69.53 |
Interest Coverage | 27.86 |
Financial Efficiency
Return on equity (ROE) is 10.57% and return on invested capital (ROIC) is 5.58%.
Return on Equity (ROE) | 10.57% |
Return on Assets (ROA) | 4.07% |
Return on Capital (ROIC) | 5.58% |
Revenue Per Employee | 1.23M |
Profits Per Employee | 74,433 |
Employee Count | 7,104 |
Asset Turnover | 0.97 |
Inventory Turnover | 5.45 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.51% in the last 52 weeks. The beta is -0.03, so Shandong Xinhua Pharmaceutical Company's price volatility has been lower than the market average.
Beta (5Y) | -0.03 |
52-Week Price Change | -6.51% |
50-Day Moving Average | 5.32 |
200-Day Moving Average | 5.49 |
Relative Strength Index (RSI) | 48.62 |
Average Volume (20 Days) | 2,757,400 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shandong Xinhua Pharmaceutical Company had revenue of HKD 8.77 billion and earned 528.77 million in profits. Earnings per share was 0.77.
Revenue | 8.77B |
Gross Profit | 2.32B |
Operating Income | 588.56M |
Pretax Income | 541.66M |
Net Income | 528.77M |
EBITDA | 1.15B |
EBIT | 588.56M |
Earnings Per Share (EPS) | 0.77 |
Balance Sheet
The company has 1.07 billion in cash and 1.51 billion in debt, giving a net cash position of -436.24 million or -0.64 per share.
Cash & Cash Equivalents | 1.07B |
Total Debt | 1.51B |
Net Cash | -436.24M |
Net Cash Per Share | -0.64 |
Equity (Book Value) | 5.35B |
Book Value Per Share | 7.43 |
Working Capital | 1.10B |
Cash Flow
In the last 12 months, operating cash flow was 346.58 million and capital expenditures -324.91 million, giving a free cash flow of 21.67 million.
Operating Cash Flow | 346.58M |
Capital Expenditures | -324.91M |
Free Cash Flow | 21.67M |
FCF Per Share | 0.03 |
Margins
Gross margin is 26.51%, with operating and profit margins of 6.71% and 6.03%.
Gross Margin | 26.51% |
Operating Margin | 6.71% |
Pretax Margin | 6.18% |
Profit Margin | 6.03% |
EBITDA Margin | 13.11% |
EBIT Margin | 6.71% |
FCF Margin | 0.25% |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 5.18%.
Dividend Per Share | 0.27 |
Dividend Yield | 5.18% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 34.81% |
Buyback Yield | -0.43% |
Shareholder Yield | 4.75% |
Earnings Yield | 14.64% |
FCF Yield | 0.61% |
Stock Splits
The last stock split was on July 6, 2018. It was a forward split with a ratio of 1.3.
Last Split Date | Jul 6, 2018 |
Split Type | Forward |
Split Ratio | 1.3 |